Lv7
3550 积分 2021-05-11 加入
With or Without Sugar? (A)glycosylation of Therapeutic Antibodies
4天前
已完结
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
15天前
已完结
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency
1个月前
已完结
Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma
1个月前
已完结
Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement
1个月前
已完结
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles
1个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
3个月前
已完结
Sequential CAR T-cell therapy in myeloma: going from BCMA to GPRC5D
3个月前
已关闭
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
3个月前
已完结
皖公网安备34019202002308
